Epigenetics player Constellation Pharma raises $5 million; launches two new clinical trials
Right on the heels of embarking on two new Phase 1 trials, epigenetics player Constellation Pharma has raised $5 million in an internal round from existing investors – a solid chunk of change. “It’s just the amount we needed to top off our balance sheet in order to take the company to a decision point for […]